Biogen Inc. buy HC Wainwright
Start price
23.03.23
/
50%
€244.95
Target price
23.03.24
€298.45
Performance (%)
-17.94%
End price
24.03.24
€201.00
Summary
This prediction ended on 24.03.24 with a price of €201.00. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.94%. HC_Wainwright has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | -3.027% | -3.027% | 29.575% | -38.131% |
| iShares Core DAX® | 1.604% | -7.448% | 3.039% | 46.264% |
| iShares Nasdaq 100 | -0.734% | -1.864% | 15.425% | 72.335% |
| iShares Nikkei 225® | 1.296% | -6.795% | 34.306% | 52.282% |
| iShares S&P 500 | -0.394% | -2.336% | 9.907% | 55.100% |
Comments by HC_Wainwright for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $325.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten